Purulent Pericarditis

Q4 Medicine
Meryem Guler BS , Sudheshna Vemula BS , Matthew Hart MD , Josh Wiener MD , Darius Farzad MD , Mark DeCaro MD , Gregary D. Marhefka MD , Devin Weber MD , John Entwistle MD, PhD , Jacqueline Urtecho MD
{"title":"Purulent Pericarditis","authors":"Meryem Guler BS ,&nbsp;Sudheshna Vemula BS ,&nbsp;Matthew Hart MD ,&nbsp;Josh Wiener MD ,&nbsp;Darius Farzad MD ,&nbsp;Mark DeCaro MD ,&nbsp;Gregary D. Marhefka MD ,&nbsp;Devin Weber MD ,&nbsp;John Entwistle MD, PhD ,&nbsp;Jacqueline Urtecho MD","doi":"10.1016/j.jaccas.2025.105152","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Purulent pericarditis is a rare, lethal complication of a bacterial pericardial infection. This case report outlines the protocol for instilling intrapericardial antibiotics for methicillin-sensitive <em>Staphylococcus aureus</em> (MSSA) pericarditis without fibrinolytics in a 51-year-old man.</div></div><div><h3>Key Steps</h3><div>An appropriately sized percutaneous pericardial drain was placed. Then, a 3-day course of intrapericardial infusions of 50 mL vancomycin was begun. Drainage of all accessible fluid was performed before each infusion. The daily infusions each had an 8-hour dwell time. The prior drainage protocol continued after each infusion.</div></div><div><h3>Potential Pitfalls</h3><div>Strict dosage and infusion length management are required to prevent direct toxicity. Potential complications include local inflammatory responses and constrictive pericarditis.</div></div><div><h3>Take-Home Messages</h3><div>The use of simultaneous intravenous and intrapericardial antibiotics were used for treating MSSA purulent pericarditis without using intrapericardial fibrinolytics in an adult. This was noted to favorably improve the purulent output and relative safety without untoward complications.</div></div>","PeriodicalId":14792,"journal":{"name":"JACC. Case reports","volume":"30 29","pages":"Article 105152"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC. Case reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666084925019321","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

Purulent pericarditis is a rare, lethal complication of a bacterial pericardial infection. This case report outlines the protocol for instilling intrapericardial antibiotics for methicillin-sensitive Staphylococcus aureus (MSSA) pericarditis without fibrinolytics in a 51-year-old man.

Key Steps

An appropriately sized percutaneous pericardial drain was placed. Then, a 3-day course of intrapericardial infusions of 50 mL vancomycin was begun. Drainage of all accessible fluid was performed before each infusion. The daily infusions each had an 8-hour dwell time. The prior drainage protocol continued after each infusion.

Potential Pitfalls

Strict dosage and infusion length management are required to prevent direct toxicity. Potential complications include local inflammatory responses and constrictive pericarditis.

Take-Home Messages

The use of simultaneous intravenous and intrapericardial antibiotics were used for treating MSSA purulent pericarditis without using intrapericardial fibrinolytics in an adult. This was noted to favorably improve the purulent output and relative safety without untoward complications.
化脓性心包炎
目的化脓性心包炎是细菌性心包感染的一种罕见的致死性并发症。本病例报告概述了一例51岁男性无纤溶性甲氧西林敏感金黄色葡萄球菌心包炎患者心包内灌注抗生素的治疗方案。关键步骤:放置适当尺寸的经皮心包引流管。然后开始心包内灌注万古霉素50ml,疗程3天。每次输注前对所有可接触的液体进行引流。每日输注的停留时间为8小时。先前的引流方案在每次输注后继续进行。潜在缺陷需要严格的剂量和输注时间管理,以防止直接毒性。潜在的并发症包括局部炎症反应和缩窄性心包炎。在不使用心包纤溶药物的情况下,同时静脉注射和心包内使用抗生素治疗一名成人的MSSA化脓性心包炎。这有利于改善脓性排出量和相对安全性,无不良并发症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
JACC. Case reports
JACC. Case reports Medicine-Cardiology and Cardiovascular Medicine
CiteScore
1.30
自引率
0.00%
发文量
404
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信